Tag: 250M
BioCryst Sells European ORLADEYO Business for $250M Upfront to Focus on US Market
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) ranks among the top stocks available for under $20. On October 1, BioCryst Pharmaceuticals…
Harvey reportedly in discussions to raise $250M at $5B valuation
Legal Tech Startup Harvey in Talks to Raise $250 Million Funding Round Legal tech startup Harvey is currently…
MobiKwik’s IPO will value it at $250M, 73% less than its last private valuation
MobiKwik Cuts IPO Size for Third Time MobiKwik, a prominent Indian financial services startup, has made significant adjustments…